09/22/2025
💊 “Generic drugs account for 90% of all prescriptions in the U.S., but they are very price-sensitive, and it’d be really difficult to move manufacturing here… while also keeping drug prices down for patients.” - Gil Roth, President, Pharma & Biopharma Outsourcing Association (PBOA)
🔊 Gil joins the podcast to unpack how tariffs, executive orders, and domestic manufacturing policies are reshaping the pharmaceutical landscape. Tune in now at www.thepulsehealthcast.com!